WO1993004586A1 - Biocidal proteins - Google Patents
Biocidal proteins Download PDFInfo
- Publication number
- WO1993004586A1 WO1993004586A1 PCT/GB1992/001574 GB9201574W WO9304586A1 WO 1993004586 A1 WO1993004586 A1 WO 1993004586A1 GB 9201574 W GB9201574 W GB 9201574W WO 9304586 A1 WO9304586 A1 WO 9304586A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- albumin
- plant
- protein
- proteins
- albumins
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 119
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 107
- 230000003115 biocidal effect Effects 0.000 title description 3
- 241000196324 Embryophyta Species 0.000 claims abstract description 77
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 37
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 29
- 239000002753 trypsin inhibitor Substances 0.000 claims abstract description 28
- 239000000203 mixture Substances 0.000 claims abstract description 25
- 108010076830 Thionins Proteins 0.000 claims abstract description 19
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 17
- 101710162629 Trypsin inhibitor Proteins 0.000 claims abstract description 11
- 229940122618 Trypsin inhibitor Drugs 0.000 claims abstract description 11
- 235000013339 cereals Nutrition 0.000 claims abstract description 6
- 229940121375 antifungal agent Drugs 0.000 claims abstract description 5
- 108010061711 Gliadin Proteins 0.000 claims abstract description 4
- 108700042314 Triticum aestivum WDAI-3 Proteins 0.000 claims abstract description 4
- 101710168820 2S seed storage albumin protein Proteins 0.000 claims description 25
- 244000052769 pathogen Species 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 19
- 230000001717 pathogenic effect Effects 0.000 claims description 19
- 241000233866 Fungi Species 0.000 claims description 16
- 108020004511 Recombinant DNA Proteins 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 8
- 101710202365 Napin Proteins 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 230000002538 fungal effect Effects 0.000 claims description 7
- 239000004599 antimicrobial Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 244000052616 bacterial pathogen Species 0.000 claims description 5
- 244000053095 fungal pathogen Species 0.000 claims description 5
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 3
- 241000209219 Hordeum Species 0.000 claims 2
- 102000009027 Albumins Human genes 0.000 abstract description 72
- 108010088751 Albumins Proteins 0.000 abstract description 72
- 240000005979 Hordeum vulgare Species 0.000 abstract description 27
- 230000003389 potentiating effect Effects 0.000 abstract description 4
- HZWWPUTXBJEENE-UHFFFAOYSA-N 5-amino-2-[[1-[5-amino-2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound C1CCC(C(=O)NC(CCC(N)=O)C(=O)N2C(CCC2)C(=O)NC(CCC(N)=O)C(O)=O)N1C(=O)C(N)CC1=CC=C(O)C=C1 HZWWPUTXBJEENE-UHFFFAOYSA-N 0.000 abstract description 2
- 208000035240 Disease Resistance Diseases 0.000 abstract description 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 80
- 239000002609 medium Substances 0.000 description 33
- 241000220259 Raphanus Species 0.000 description 29
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 29
- 108010026134 purothionin Proteins 0.000 description 29
- 240000002791 Brassica napus Species 0.000 description 23
- 201000010099 disease Diseases 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 230000000694 effects Effects 0.000 description 22
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 21
- 230000002829 reductive effect Effects 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 11
- 239000002299 complementary DNA Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 150000001413 amino acids Chemical group 0.000 description 9
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 9
- 230000002195 synergetic effect Effects 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 241000223194 Fusarium culmorum Species 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000013604 expression vector Substances 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 230000009261 transgenic effect Effects 0.000 description 8
- 238000010276 construction Methods 0.000 description 7
- 101000757775 Mirabilis jalapa Antimicrobial peptide 2 Proteins 0.000 description 6
- 102000001708 Protein Isoforms Human genes 0.000 description 6
- 108010029485 Protein Isoforms Proteins 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 241001273451 Ascochyta pisi Species 0.000 description 5
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 241001123668 Verticillium dahliae Species 0.000 description 5
- 239000001110 calcium chloride Substances 0.000 description 5
- 229910001628 calcium chloride Inorganic materials 0.000 description 5
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 5
- 238000013207 serial dilution Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 4
- 241000223600 Alternaria Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000021536 Sugar beet Nutrition 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000006008 Brassica napus var napus Nutrition 0.000 description 3
- 241000701489 Cauliflower mosaic virus Species 0.000 description 3
- 241000530549 Cercospora beticola Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 3
- 108091034057 RNA (poly(A)) Proteins 0.000 description 3
- 108010016634 Seed Storage Proteins Proteins 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 239000001166 ammonium sulphate Substances 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 239000000074 antisense oligonucleotide Substances 0.000 description 3
- 238000012230 antisense oligonucleotides Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000000417 fungicide Substances 0.000 description 3
- 230000009036 growth inhibition Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 239000000280 phytoalexin Substances 0.000 description 3
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 3
- 239000001965 potato dextrose agar Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- 241000194107 Bacillus megaterium Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 238000011483 antifungal activity assay Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 208000030499 combat disease Diseases 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 244000000004 fungal plant pathogen Species 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- IRHWMYKYLWNHTL-UHFFFAOYSA-M sodium 2-(N-morpholino)ethanesulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCN1CCOCC1 IRHWMYKYLWNHTL-UHFFFAOYSA-M 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 210000003606 umbilical vein Anatomy 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- VHJLVAABSRFDPM-UHFFFAOYSA-N 1,4-dithiothreitol Chemical compound SCC(O)C(O)CS VHJLVAABSRFDPM-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 1
- 101710083587 Antifungal protein Proteins 0.000 description 1
- 101710170231 Antimicrobial peptide 2 Proteins 0.000 description 1
- 101710147630 Antimicrobial protein 2 Proteins 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- 241000589938 Azospirillum brasilense Species 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 244000045232 Canavalia ensiformis Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000713575 Homo sapiens Tubulin beta-3 chain Proteins 0.000 description 1
- 101710123134 Ice-binding protein Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 244000022198 Mirabilis jalapa Species 0.000 description 1
- 235000009053 Mirabilis jalapa Nutrition 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000588701 Pectobacterium carotovorum Species 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 239000012564 Q sepharose fast flow resin Substances 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 241000589771 Ralstonia solanacearum Species 0.000 description 1
- 235000019057 Raphanus caudatus Nutrition 0.000 description 1
- 235000011380 Raphanus sativus Nutrition 0.000 description 1
- 108090000829 Ribosome Inactivating Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 241000227728 Trichoderma hamatum Species 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 101710112930 Trypsin inhibitor 1 Proteins 0.000 description 1
- 101710112927 Trypsin inhibitor 2 Proteins 0.000 description 1
- 102100036790 Tubulin beta-3 chain Human genes 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241001672648 Vieira Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000003277 amino acid sequence analysis Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 101150059062 apln gene Proteins 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 241000385736 bacterium B Species 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 244000037666 field crops Species 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- 229940045883 glutathione disulfide Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000012135 ice-cold extraction buffer Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000000765 microspectrophotometry Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229940079938 nitrocellulose Drugs 0.000 description 1
- 239000011824 nuclear material Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000010405 reoxidation reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 238000002723 toxicity assay Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 229960001814 trypan blue Drugs 0.000 description 1
- ZBNARPCCDMHDDV-HVMBLDELSA-N trypan blue sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C=C(S(O)(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S(O)(=O)=O)S(O)(=O)=O)C)=C(O)C2=C1N ZBNARPCCDMHDDV-HVMBLDELSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/40—Liliopsida [monocotyledons]
- A01N65/44—Poaceae or Gramineae [Grass family], e.g. bamboo, lemon grass or citronella grass
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
Definitions
- This invention relates to biocidal proteins and compositions, and processes for their manufacture and use.
- it relates to the antimicrobial activity of seed storage proteins, and to their synergistic activity with other antimicrobial proteins isolated from plants.
- antimicrobial activity includes a range of antagonistic effects (such as partial inhibition or death) on a fungus and/or a bacterium.
- the invention relates to antifungal (which may include anti-yeast) activity.
- plants normally grow on substrates that are extremely rich in fungal organisms, infection remains a rare event.
- plants produce a wide array of antifungal compounds, either in a constitutive or an inducible manner.
- the best studied of these are phytoalexins, secondary metabolites with a broad antimicrobial activity spectrum that are specifically synthesised upon perception of appropriate defence-related signal molecules.
- the production of phytoalexins depends on the transcriptional activation of a series of genes encoding enzymes of the phytoalexin biosynthetic pathway. During the last decade, however, it has become increasingly clear that some plant proteins can play a more direct role in the control of phytopathogenic fungi.
- thionins are basic cysteine-rich plant proteins that are thought to be involved in host defence (Rodriguez-Palenzuela et al, 1988, Gene, 70, 271-280).
- the 2S albumins are, together with the 7S and IIS globulins, the main protein components in seeds of several' different plant families, including the Brassicaceae (Higgins, 1984, Ann Rev Plant Physiol, 35, 191-221). They serve as storage molecules providing nitrogen and sulphur for the germinating seedling.
- the 2S albumins have been well studied in rapeseed (Brassica napus) , where these proteins are termed napins.
- Napins are composed of two different chains of about 4 kDa (small subunit) and 9.5 kDa (large subunit), held together by two disulphide bridges. Both subunits originate from the same 21 kDa precursor polypeptide by post-translational proteolytic processing events
- seed storage proteins may have secondary functions related to the protection of seeds from damage caused by animals or micro-organisms.
- no such function has ever been attributed to 2S storage albumins.
- albumin-type proteins exhibit surprising antifungal activity, and may be used as fungicidal agents.
- these proteins exhibit a surprising and unique property in that they can potentiate the antifungal activity of thionins: in some cases up to 70-fold.
- an antimicrobial composition comprising an albumin-type protein.
- the said protein may be a functional polypeptide subunit of an oligomeric protein.
- the composition may contain more than one protein.
- the invention provides a process of combating fungi or bacteria by exposure to such a composition.
- the 2S albumins and related proteins show surprising activity: they inhibit the growth of a variety of plant pathogenic fungi.
- the antifungal properties of 2S albumins from rapeseed and radish and of a trypsin inhibitor from barley have been demonstrated.
- the antifungal activity of 2S albumins resides mainly in the small subunit of these proteins, and may be antagonised by K + and Ca + at physiological concentrations.
- the albumin-type proteins (2S albumins and related proteins) show a wide range of antifungal activity, and could be used as fungicides by application to plant parts (or surrounding soil) using standard agricultural techniques (such as spraying) .
- Pathogens exposed to the proteins are inhibited.
- the protein may eradicate a pathogen already established on the plant or the protein may protect the plant from future pathogen attack.
- the eradicant effect of the antimicrobial proteins is particularly advantageous
- the antimicrobial proteins can be extracted and purified from plant material, manufactured from their known amino acid sequence by chemical synthesis using a standard peptide synthesiser, or produced within a suitable organism by expression of reco binant DNA.
- DNA encoding the proteins can be manufactured using a standard nucleic acid synthesiser, or suitable probes (derived from the known sequence) can be used to isolate the actual gene( ⁇ ) and control sequences from a plant genome. This genetic material can then be cloned into a biological system which allows expression of the proteins.
- the proteins can be produced in a suitable micro-organism or cultured cell, extracted and isolated for use.
- Suitable micro-organisms may include Escherichia coli and Saccharomyces cerevisiae.
- Suitable cells may include cultured insect cells and cultured mammalian cells.
- the antimicrobial proteins may also be used to combat disease by expression of DNA encoding one or more of said proteins within transgenic plant bodies. The fungus or bacterium is thus exposed to the protein at the site of pathogen attack on the plant.
- the albumins seed proteins
- the albumins may be produced i ⁇ vivo within parts of the plant where they are not normally expressed in quantity but where disease resistance is important (such as in the leaves).
- Plant cells may be transformed with recombinant DNA constructs according to a variety of known methods (Agrobacterium Ti plasmid ⁇ , electroporation, microinjection, microprojectile gun, etc).
- the transformed cells may then in suitable cases be regenerated into whole plants in which the new nuclear material is stably incorporated into the genome. Both transformed monocot and dicot plants may be obtained in this way, although the latter are usually more easy to regenerate.
- the progeny of these primary transformants will inherit the recombinant DNA encoding the antimicrobial protein(s).
- genetically modified plants which may be produced include field crops, cereals, fruit and vegetables such as: canola, sunflower, tobacco, sugarbeet, cotton, soya, maize, wheat, barley, rice, sorghum, tomatoes, mangoes, peaches, apples, pears, strawberries, bananas, melons, potatoes. carrot, lettuce, cabbage, onion.
- the invention further provides a plant having improved resistance to a fungal or bacterial pathogen and containing recombinant DNA which expresses an albumin-type protein.
- a pathogen may be any fungus or bacterium growing on, in or near the plant.
- improved resistance is defined as enhanced tolerance to a fungal or bacterial pathogen when compared to a wild-type plant. Resistance may vary from a slight increase in tolerance to the effects of the pathogen (where the pathogen in partially inhibited) to total resistance so that the plant is unaffected by the presence of pathogen (where the pathogen is severely inhibited or killed) . An increased level of resistance against a particular pathogen or resistance against a wider spectrum of pathogens may both constitute an improvement in resistance.
- Recombinant DNA is heterologous DNA which has been introduced into the plant.
- the recombinant DNA encodes an antimicrobial protein expressed for delivery to a site of pathogen attack (such as the leaves).
- the DNA may encode an active subunit of an antimicrobial protein, such as the small subunit (SS) of 2S albumin described in Example 10.
- the invention further provides an antimicrobial composition
- an antimicrobial composition comprising an albumin-type protein and a thionin protein. Either or both of said proteins may be a functional polypeptide subunit of an oligomeric protein.
- the composition may contain more than one albumin-type protein and/or more than one thionin protein.
- the invention provides a process of combating fungi or bacteria by exposure to such a composition.
- the synergism exhibited between the albumins and the thionins is the synergism exhibited between the albumins and the thionins.
- the unexpectedly potent antifungal activity of the albumin/thionin mixture can be exploited to combat plant disease.
- the mixture may be used as a fungicide by application to plant parts (or surrounding soil) using standard agricultural techniques (such as spraying).
- Pathogens exposed to the proteins are inhibited.
- the protein may eradicate a pathogen already established on the plant or the protein may protect the plant from future pathogen attack.
- the eradicant effect of the antimicrobial proteins is particularly advantageous.
- the antimicrobial proteins can be extracted and purified from plant material, manufactured from their known amino acid sequence by chemical synthesis using a standard peptide synthesiser, or produced within a suitable organism by expression of recombinant DNA as previously described.
- the proteins may also be be used to combat disease by expression within transgenic plant bodies as previously described.
- the invention further provides a plant having improved resistance to a fungal or bacterial pathogen and containing recombinant DNA which expresses an albumin-type protein and a thionin protein.
- a plant with an inherent thionin content may be transformed with DNA encoding one or more albumin proteins, so that a mixture of the two classes of protein is produced ⁇ n vivo.
- DNA encoding one or more thionins can be transformed into a plant and expressed within tissue which has an inherent albumin content.
- a third possibility is to transform both DNA encoding one or more albumins and DNA encoding one or more thionins into a plant, so that both classes of protein are expressed together in the same tissue.
- the albumin-encoding DNA may be introduced on the same construct as the thionin-encoding DNA, or on a separate construct.
- Another possibility is to transform a first plant with DNA encoding an albumin-type protein and to transform a second plant with DNA encoding a thionin protein, and then to cross the first and second plants producing a plant containing recombinant DNA expressing both proteins.
- Figure 1 is the chromatogram for the protein fraction extracted from radish seed.
- Figure 2 is the chromatogram for the protein fraction extracted from rapeseed seed.
- Figure 3 shows the SDS-PAGE analysis of the reduced and unreduced radish 2S albumins.
- Figure 4 shows the SDS-PAGE analysis of the reduced and unreduced rapeseed 2S albumins.
- Figure 5 shows the reversed-phase chromatogram of the reduced and carboxyamidomethylated Rs-2S5, a radish 2S albumin.
- Figure 6 shows the amino acid sequences of the 2S albumins Rs-2S5, pBa3 and napin.
- Figure 7 shows the N-terminal amino acid sequences of the trypsin inhibitors from barley and wheat.
- Figure 8 is a graph showing the degree of Cercospora beticola disease on sugarbeet against rate of 2S albumin application.
- Figure 9 is a graph showing the degree of
- Figure 10 shows the nucleotide sequence of the 2S albumin gene pIG8.
- Figure 11 shows the nucleotide sequence and derived amino acid sequence of the small subunit of 2S albumin fused to the MJ-AMP2 signal peptide.
- Figure 12 shows the construction of the expression vector pIGl3.
- Figure 13 shows the construction of the expression vector pIGl ⁇ .
- Figure 14 shows the construction of the plant transformation vector pIG19.
- Figure 15 shows the construction of the plant transformation vector pIG20.
- EXAMPLE 1 Isolation of 2S albumins from radish and rapeseed seeds.
- 2S albumins were isolated from radish seeds and rapeseed seeds by a four-step procedure including ammonium sulphate fractionation, heat treatment, anion exchange chromatography and cation exchange chromatography. The detailed methods are described below.
- One kg of radish or rapeseed seeds was ground in a coffee mill and the resulting meal was extracted for 2 hours at 4°C with 2 litres of an ice-cold extraction buffer containing 10 mM NaH 2 P0 4 , 15 mM Na 2 HP0 4 , 100 mM KC1, 2 mM EDTA, 2 mM thiourea and 1 mM PMSF.
- the homogenate was squeezed through cheesecloth and clarified by centrifugation (30 min at 7,000 x g). Solid ammonium sulphate was added to the supernatant to obtain 30% relative saturation and the precipitate formed after standing overnight at room temperature was removed by centrifugation (30 minutes at 7,000 x g) .
- the supernatant was adjusted to 70% relative ammonium sulphate saturation and the precipitate formed overnight at room temperature collected by centrifugation (30 min at 7,000 x g). After redissolving the pellet in 400 ml H-0 the solution was heated at 80°C for 15 min. The coagulated insoluble material was removed by centrifugation (30 min at 7000 x g) and the supernatant was dialyzed extensively against distilled water using dialysis tubing (SpectralPor, Spectrum, USA) with a molecular weight cut off of 1000 Da.
- the protein fractions corresponding to these peaks are henceforward designated as Rs-2S1, Rs-2S2, Rs-2S3, Rs-2S4 and Rs-2S5, respectively, for the radish 2S albumins ( Figure 1) and Bn-2S1, Bn-2S2, Bn-2S3, Bn-2S4 and Bn-2S5 respectively for the rapeseed 2S albumins ( Figure 2).
- the isolated isoforms of 2S albumins from radish and rapeseed were analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) before and after reduction with dithiothreitol.
- SDS-PAGE was performed on precast commercial gels (PhastGel High Density from Pharmacia) using a PhastSystem (Pharmacia) electrophoresis apparatus.
- the sample buffer for analysis of unreduced proteins contained 200 mM Tris-HCl (pH 8.3), 1% (w/v) SDS, 1 M EDTA, 0.005% bromophenol blue, and the sample buffer for analysis of reduced proteins contained a supplement of 1% (w/v) dithiothreitol (DTT).
- the unreduced proteins were fixed in 30% (v/v) ethanol/10% (v/v) acetic acid and were silver-stained according to Heukeshoven and Dernick (1985, Electrophoresis, 6, 103-112).
- the reduced proteins were blotted on nitro-cellulose after electrophoresis and the blots were silver-stained according to Kovarik et al (1987, Folia Biologica, 33, 253-257).
- Figure 3 shows the SDS-PAGE analysis of the radish 2S albumins in their unreduced (left panel) and reduced (right panel) forms.
- Lanes 1 show Rs-2S1, lanes 2 show Rs-2S2, lanes 3 show Rs-2S3, lanes 4 show Rs-2S4, lanes 5 show Rs-2S5.
- Figure 4 shows the SDS-PAGE analysis of the rapeseed 2S albumins in their unreduced (left panel) and reduced (right panel) forms.
- Lanes 1 show Bn-2S1, lanes 2 show Bn-2S2, lanes 3 show Bn-2S3, lanes 4 show Bn-2S4, lanes 5 show Bn-2S5.
- Lanes M show myoglobin fragments used as molecular weight markers (Pharmacia) with the following sizes: 17 kDa, 14.5 kDa, 8 kDa, 6 kDa, and 2.5 kDa.
- the reduced radish 2S albumins migrate as 2 bands of about 9 and 4 kDa, respectively.
- the different isoforms yield doublets with an apparent molecular weight of 17 and 18 kDa, respectively.
- the column was eluted at 1 ml/min with a linear gradient (90 min) from 0 to 45% acetonitrile in 0.1% trifluoracetic acid.
- Figure 5 shows the resulting chromatogram: the mixture separated into 2 groups of 3 peaks each. SDS-PAGE analysis of the different peaks revealed that peaks 1, 2 and 3 correspond to the small subunit (4 kDa) and peaks 4, 5 and 6 to the large subunit (9 kDa).
- the N-terminal sequence of material from peak 1 (small subunit) and peak 4 (large subunit) was determined by the Edman degradation method on a pulsed liquid-phase sequencer (Applied Biosystems model 477A/120). For the small subunit of RS-2S5 (peak 1, Figure 5) 30 residues could be identified, whereas for the large subunit of Rs-2S5 (peak 4, Figure 5) 20 amino acids were sequenced.
- barley Hordeum vulgare L.
- barley trypsin inhibitor that is highly homologous to 2S albumins from dicotyledonous species.
- the barley trypsin inhibitor hereafter called btiO
- btiO barley trypsin inhibitor
- btiO was isolated by the procedure of Mikola and Suolinna (1969, Eur J Biochem, 9, 555-560). The preparation was further purified by an additional step consisting of reversed-phase chromatography on a Pep S (porous silica C2/C18) column (25 x 0.93 cm) (Pharmacia). The column was eluted at 5 ml/min with a linear gradient (40 min) from 0 to 40% acetonitrile. The identity of the purified protein as btiO was verified by N-terminal amino acid sequencing. The first 11 N-terminal residues were identical to those previously reported (Odani e_t al, 1983, J Biol Chem, 258, 7998-8000).
- bti-1 barley trypsin inhibitor 1
- bti2 barley trypsin inhibitor 2
- Figure 7 shows the N-terminal amino acid sequences of the trypsin inhibitors from barley and from WG11. ⁇ -Purothionin was isolated from wheat
- the purothionin eluted was two incompletely resolved peaks at 34 and 35% acetonitrile, respectively, which represent the ⁇ l and ⁇ 2 isofor (Mak and Jones, 1977, Cereal Chem, 54, 511-523). Both isoforms were pooled, to yield the o-purothionin preparation.
- Antifungal activity assay was measured by microspectrophoto etry as previously described
- the synthetic growth medium consisted of K-HPO ⁇ (2.5 mM), MgS0 4 (50 ,vM), CaCl 2 (50 //M) , FeS0 4 (5 ⁇ VL) , C ⁇ Cl 2 (0.1 ⁇ K) , CuS ⁇ 4 (0.1 ⁇ K ) , a 2 Mo0 4 (2 ,vM) , H 3 B0 3 (0.5 ⁇ ) , KI (0.1 /M) , ZnS0 4 (0.5 /M), MnS0 4 (0.1 ⁇ ) , glucose (lOg/l), asparagine (lg/1), methionine (20 mg/1), myo-inositol (2 mg/1), biotin (0.2 mg/1), thiamine-HCl (1 mg/1), and pyridoxine-HCl (0.2 mg/1). Control microculture
- Percent growth inhibition is defined as 100 times the ratio of the corrected absorbance of the control microculture minus the corrected absorbance of the test microculture over the corrected absorbance at 595 nm of the control microculture.
- the corrected absorbance values equal the absorbance at 595 nm of the culture measured after 48 hours minus the absorbance at 595 nm measured after 30 minutes.
- the antifungal potency of the radish 2S albumins, rapeseed 2S albumins, barley trypsin inhibitors and ⁇ -purothionin was assessed by the microspectrophotometric assay described in Example 4. Growth of fungi, collection and harvest of spores was done as previously described (Broekaert et al, 1990, FEMS Microbiol Lett, 69, 55-60). Four different plant pathogenic fungi were used as test organisms: Fusarium culmorum IMI 180420, Alternaria brassicola MUCL 20297, Ascochyta pisi MUCL 30164, and Verticillium dahliae MUCL 19210.
- medium A was half-strength potato dextrose broth
- medium B was medium A supplemented with 1 mM CaCl 2 and 50 mM KCl.
- the constitution of monovalent and divalent cations of medium B is such that it resembles that inside a plant cell.
- medium B high ionic strength
- the 2S albumins and the barley trypsin inhibitors were completely inactive at concentrations up to 1 mg/ml.
- the ⁇ -purothionin remained active in medium B, although its specific activity was decreased by about two- to four-fold in medium B relative to medium A.
- the effect of ions on the antifungal activity of radish 2S albumins was examined in more detail.
- the IC CQ values of Rs-2S3 on Fusarium culmorum and Trichoderma hamatum MUCL 29736 were measured in five different media.
- the reference medium was the synthetic growth medium described in Example 4, which contains a total of 2.5 mM monovalent cations and 0.1 mM divalent cations.
- the four other media contained 10 mM KCl, 50 mM KCl, 1 mM CaCl 2 or 5 mM CaCl 2 in supplement, respectively. Results are shown in Table 2. TABLE 2 VARIATION IN ANTIFUNGAL ACTIVITY OF RS-2S3 IN PRESENCE OF K + AND CA 2+
- EXAMPLE 7 Synergism between 2S albumins, barley trypsin inhibitor and ⁇ -purothionin.
- the Synergism Factor was calculated as the ratio of the C 50 value in the control series (no 2S albumins or trypsin inhibitors added) over the IC 5Q value in the series supplemented with 2S albumin or barley trypsin inhibitors. Synergism Factors are rounded to the nearest integer.
- the synergism factors obtained in medium A were generally about two to three-fold higher than those obtained in medium B.
- the highest synergism factor (73) was obtained in medium B for the combination of ⁇ -purothionin and Bn-2S3 (at 250 ⁇ q/ml ) on the fungus Alternaria brassicola.
- the synergism factors increased drastically when the subinhibitory concentration of 2S albumins in medium B was raised from 10 to 50 ,vg/ml, but except for A brassicola, no further substantial increase was obtained on going from 50 to 250 ⁇ q/ml.
- the synergism factors were generally between two and five-fold lower compared to the 2S albumins RS-2S3 and Bn-2S3.
- EXAMPLE 8 Effect of 2S albumins and ⁇ -purothionin on bacterial growth.
- a bacterial suspension was prepared by inoculating either soft agarose medium C (10 g/1 tryptone, 5 g/1 Seaplaque agarose FMC), or soft agarose medium D (10 g/1 tryptone, 5 g/1 Seaplaque agarose (FMC),
- the following bacterial species were used: Agrobacterium tumefaciens LMG 188, Alcaligenes eutrophus LMG 1195, Azospirillum brasilense ATCC 29145, Bacillus megaterium ATCC 13632, Erwinia carotovora strain 3912, Escherichia coli strain HB101, Pseudomonas solanacearum LMG 2293, Sarcina lutea ATCC 9342.
- RS-2S3 was assessed by adding serial dilutions of the protein to bacterial suspensions. The highest test concentration was 500 ⁇ q/ml (final concentration) .
- Rs-2S3 only affected the growth of the gram-positive bacterium B megaterium (IC ⁇ 0 « 10/g/ml) and the gram-negative bacterium E carotovora (IC 50 - 250,vg/ml). However, when the growth medium C was supplemented with 1 mM CaCl- and 50 mM KCl (medium D), Rs-2S3 lost its inhibitory activity on these bacteria.
- Synergisms in antibacterial activity were assessed for combinations between Rs-2S3 and ⁇ -purothionin by using the same approach as described in Example 7. A synergistic effect was observed on B megaterium.
- synergism factors of 4, 15 and 17 were obtained after addition of Rs-2S3 at subinhibitory concentrations of 10, 50 and 250 ⁇ q/ml , respectively, to a serial dilution series of ⁇ -purothionin (Table 4).
- the thionin-potentiating activity of 2S albumin is not limited to fungi, but is also evident on some bacterial species.
- EXAMPLE 9 Effect of 2S albumins and ⁇ -purothionin on cultured human cells.
- Human cell toxicity assays were performed either on umbilical vein endothelial cells (Alessi et al, 1988, Eur J Biochem, 175, 531-540) or skin-muscle fibroblasts (Van Damme et al, 1987, Eur J Immunol, 17, 1-7) cultured in 96-well microplates. The growth medium was replaced by 80 ⁇ l of serum-free medium (Optimem 1 for endothelial cells or Eagle's minimal essential medium (EMEM) for fibroblasts, both from GIBCO), to which 20 ,vl of a filter-sterilised test solution was added. The cells were further incubated for 24 hours at 37°C under a 5% C0 2 atmosphere with 100% relative humidity.
- EMEM Eagle's minimal essential medium
- the viability of the cells was assessed microscopically after staining with trypane blue (400 mg/1 in phosphate buffered saline, PBS) for 10 minutes. Alternatively, cells were stained with neutral red (56 ml/1 in PBS) for 2 hours at 37°C. Neutral red treated cells were washed with PBS, lysed in acidic ethanol (30 mM sodium citrate, pH 4.2, containing 50% ethanol) and scored for release of the dye by microspectrophotometry at 540 nm. The 2S albumins were evaluated for their potential toxic effects on mammalian cells.
- RS-2S3 When added at up to 500 ,vg/ml to either cultured human umbilical vein endothelial cells or human skin-muscle fibroblasts, RS-2S3 did not affect cell viability after 24 hours of incubation. In contrast, ⁇ -purothionin administered at 50 ⁇ q/ml and 20 ⁇ q/ml decreased the viability of both cell types by more than 90% and 50%, respectively. Addition of Rs-2S3 at a constant concentration of 250 ⁇ g/ml to a serial dilution series of a ⁇ -purothionin did not increase the toxic activity of the - ⁇ -purothionin.
- the small subunit (SS) and the large subunit (LS) of RS-2S3 were prepared as follows.
- RS-2S3 was reduced in 100 mM Tris-HCl, pH 8.4, 100 mM DTE and kept at 45°C for 1 hour. After reduction the preparation was passed over a reversed phase column as described in Example 2. The peaks corresponding to SS and LS, respectively, were pooled and vacuum-dried.
- the cysteine residues of the SS and LS preparations were reoxidised using an oxido-shuffling system consisting of reduced glutathione and glutathione disulphide as described by Jaenicke and Rudolph (1989, In: Creighton (ed). Protein structure: a practical approach.
- Test protein cone Test protein cone.
- Table 5 shows that SS as well as LS (though to a much lesser extent) are able to potentiate the activity of ⁇ -purothionin.
- a synergism factor of up to 33 could be obtained when oxidised SS was added at 10 ⁇ q/ml to a dilution of ⁇ -purothionin and assayed in medium A.
- medium B a synergism factor of 2 was measured under these conditions.
- a synergism factor of 14 was obtained when oxidised SS was added at 50 ⁇ q/ml in medium B.
- Low synergism factors were measured during the same experiments with the oxidised LS.
- EXAMPLE 11 Anti—fungal activity of the 2S albumins against foliar disease: ii vivo test Radish 2S albumins were tested against the sugarbeet foliar disease Cercospora beticola (strain K897) to establish whether they exhibited any in vivo anti-fungal activity. Sugarbeet plants were grown in John Innes potting compost ( No. 1 or 2 ) in 4cm diameter mini-pots. 27 day old plants were used for the tests. The protein preparation was formulated immediately prior to use by dissolving in sterile distilled water and diluting to the appropriate concentration. The samples were applied to the plants as a foliar spray to maximum discrete droplet retention.
- the protein formulations were applied either one day prior to inoculation with the disease (1 day protectant assay) or 48 hours after disease inoculation (2 day eradicant assay).
- the pathogen was applied as a foliar spray at a concentration of 50,000 spores/ml. Following inoculation the plants were kept in a humidity chamber for 48 hours and the plants then moved to a 24°C growth room. Disease was assessed after a further 12 days.
- Results are shown in Figure 8.
- the 2S albumins gave good disease control at rates of between 100 uM and 700 uM.
- Double stranded cDNAs were prepared from 1,5 ⁇ q of poly(A) + RNA according to Gubler and Hoffman (1983, Gene 25, 263-269) and ligated to EcoRI/NotI adaptors using the cDNA Synthesis Kit of Pharmacia. The cDNAs were cloned into the lambda ZAPII phage vector (Stratagene) according to the manufacturers instructions. One of the radish 2S albumin cDNAs was cloned by performing PCR (polymerase chain reaction) (under standard conditions : Sambrook et al.
- OWB20 was designed based on the published sequence of the radish 2S albumin pBA3 cDNA (Raynal et al, 1991, Gene 99, 77-86).
- OWB18 was designed based on the published sequence of the oilseed rape napin pNAPl cDNA (Ericson e_t al, 1986, J. Biol. Chem. 261, 14576-14581). OWB18 has the TAAGGATCC ('TAA' followed by the BamHI recognition site) at its 5' end and OWB20 the TAATCTAGA ('TAA' followed by the Xbal recognition site).
- the PCR-product was cut with BamHI and Xbal, subcloned into pEMBL18+ pre-digested with the same enzymes and subjected to automated nucleotide sequencing on a Pharmacia ALF Automated Nucleotide Sequencer.
- the nucleotide sequence of this clone (hereafter called pIG8) is given in Figure 10 (the signal peptide is underlined with a dashed line, the mature small subunit is underlined with a full line, the mature large subunit is boxed).
- OWB19 carries the TAATCTAGACTA sequence ('TAA' followed by the Xbal recognition site and 'CTA' which introduces the stop codon 'TAG') at its 5' end and OWB21 carries at its 5' end the AATTGCTAGC sequence ( 'AAT r followed by the Nhel recognition site).
- the Mirabilis jalapa antimicrobial protein 2 (Mj- AMP2 ; Cammue et al, 1992, J. Biol. Chem.
- the MJ-AMP2 signal peptide PCR-product was cut with BamHI (occurring in the polylinker of pMJ9) and Xbal and cloned into pEMBLl8+ pre-digested with the same enzymes.
- the additional ATG start-codon upstream of the MJ-AMP2 start-codon was removed by cutting the obtained construct with EcoRV and Smal followed by blunt ligation. This resulted in the clone pIGlO.
- the radish 2S albumin small subunit PCR-product was cut with NheI and Xbal and cloned into pIGlO pre-digested with NheI.
- NheI and Xbal produce compatible ends
- the orientation of the inserted small subunit was checked by digestion of different clones with Nhel and BamHI.
- One of the clones with the correctly inserted small subunit, pIGll was subjected to automated nucleotide sequence analysis.
- the nucleotide sequence and the derived amino acid sequence of the pIGll insert are given in Figure 11. Note that the first amino acid of the small subunit (a proline, see Fig. 10) has been changed into a serine.
- oilseed rape napins have a serine as the first amino acid of their small subunit (Ericson et al, 1983, J. Biol. Chem. 261, 14576-14581) and also exert antifungal activity and display the synergistic effect with the ⁇ -purothionin (see Examples 5 and 10), this substitution is not believed to affect nor the antifungal activity nor the synergistic effect of this altered radish 2S albumin small subunit.
- EXAMPLE 14 Construction of the expression vectors pIG13 and plGlS.
- the expression vector pIGl3 ( Figure 12) contains the full coding region of the Rs-2S albumin cDNA flanked at its 5' end by the strong constitutive promoter of the 35S RNA of the cauliflower mosaic virus (Odell e_t al ⁇ , 1985, Nature 313, 810-812) with a duplicated enhancer element to allow for high transcriptional activity (Kay e_t al, 1987, Science 236, 1299-1302).
- the coding region of the Rs-2S albumin cDNA is flanked at its 3' end side by the polyadenylation sequence of 35S RNA of the cauliflower mosaic virus (CaMV35S).
- pIG13 was constructed as follows : clone pIG8 which consisted of the Rs-2S albumin cDNA ( Figure 10) cloned into the Kpnl / PstI sites of pEMBLl8+ (Boehringer) . The 298 bp Kpnl / PstI fragment was subcloned into the expression vector pFAJ3002 which was pre-digested with Kpnl and PstI. pFAJ3002 is a derivative of the expression vector pFFl9 (Timmermans et al.
- the expression vector pIG15 ( Figure 13) contains the hybrid nucleotide sequence coding for the MJ-AMP2 signal peptide followed by the Rs-25 albumin small subunit and was constructed in the same way as pIG13 though starting from pIGll ( Figure 11) .
- EXAMPLE 15 Construction of the plant transformation vector pIG19 and pIG20.
- pBinl9Ri is a modified version of the plant transformation vector pBinl9 (Bevan 1984, Nucleic Acids Research 12, 8711-8721) wherein the unique EcoRI and Hindlli sites are switched and the defective nptll expression cassette (Yenofsky et a_l, 1990, Proc. Natl. Acad. Sci. USA 87:3435-3439) is introduced.
- the new plant transformation vector is designated pIG19 ( Figure 14).
- the new plant transformation vector pIG20 was constructed in the same way as pIG19 with the exception that the Hindlli fragment of pIG15 (containing the hybrid MJ-AMP2 signal peptide / Rs-2S albumin small subunit expression cassette) was subcloned in pBinl9Ri ( Figure 15).
- LBA4404 (pAL4404) (Hoekema et. al, 1983, Nature 303, 179-180) was transformed with the vectors pIGl9 or pIG20 using the method of de Framond e_t al, (BioTechnology 1, 262-269). Tobacco transformation was carried out using leaf discs of Nicotiana tabacum Samsun based on the method of Horsch et al, (1985, Science 227, 1229- 1231) and co-culturing with Agrobacterium strains containing pIG19 or pIG20. Co-cultivation was carried out under selection pressure of 100 ⁇ q/ml kanamycin.
- Transgenic plants (transformed with pIG19 or pIG20) were regenerated on media containing 100 ⁇ q/ml kanamycin. These transgenic plants may be analysed for expression of the newly introduced genes using standard western blotting techniques. Plants capable of constitutive expression of the introduced genes may be selected and self-pollinated to give seed. Fl seedlings of the transgenic plants may be further analysed.
- transgenic homozygous plants in the pIGl9 or in the plG20 trait
- transgenic thionin-homozygous tobacco plants may be crossed with transgenic thionin-homozygous tobacco plants.
- the new transgenic plants may be analysed as above.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Agronomy & Crop Science (AREA)
- Mycology (AREA)
- Dentistry (AREA)
- Botany (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5505025A JPH06510535A (en) | 1991-09-02 | 1992-08-28 | biocidal protein |
EP92918332A EP0602098A1 (en) | 1991-09-02 | 1992-08-28 | Biocidal proteins |
AU24847/92A AU665020B2 (en) | 1991-09-02 | 1992-08-28 | Biocidal proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9118730.2 | 1991-09-02 | ||
GB9118730A GB9118730D0 (en) | 1991-09-02 | 1991-09-02 | Biocidal proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993004586A1 true WO1993004586A1 (en) | 1993-03-18 |
Family
ID=10700780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1992/001574 WO1993004586A1 (en) | 1991-09-02 | 1992-08-28 | Biocidal proteins |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0602098A1 (en) |
JP (1) | JPH06510535A (en) |
AU (1) | AU665020B2 (en) |
GB (1) | GB9118730D0 (en) |
NZ (1) | NZ244127A (en) |
WO (1) | WO1993004586A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995018859A1 (en) * | 1994-01-10 | 1995-07-13 | Ciba-Geigy Ag | Synergistic antifungal protein and compositions containing same |
EP0712272A4 (en) * | 1993-07-16 | 1997-08-20 | Salk Inst For Biological Studi | TRANGENIC PLANTS CONTAINING MULTIPLE DISEASE RESISTANCE GENES |
FR2778407A1 (en) * | 1998-05-11 | 1999-11-12 | Agronomique Inst Nat Rech | Use of polypeptide as insecticide, especially for controlling cereal grain pests |
AU718210B2 (en) * | 1997-09-08 | 2000-04-13 | National Institute Of Agrobiological Sciences | Disease resistant plant including thionin gene |
US6121436A (en) * | 1996-12-13 | 2000-09-19 | Monsanto Company | Antifungal polypeptide and methods for controlling plant pathogenic fungi |
WO2000071735A1 (en) * | 1999-05-21 | 2000-11-30 | Syngenta Limited | Composition of plant antimicrobial proteins |
NL1011688C2 (en) * | 1998-03-27 | 2001-09-13 | Academia Sinica | Amphipathic Protein-1. |
US6599514B1 (en) | 1997-07-10 | 2003-07-29 | Syngenta Limited | Antifungal composition |
US7544861B2 (en) * | 2001-02-08 | 2009-06-09 | Hexima Limited | Defensin-encoding nucleic acid molecules, uses therefor and transgenic plants comprising same |
CN101544982B (en) * | 2008-12-09 | 2011-05-04 | 四川农业大学 | Novel nucleic acid sequence of gamma-alcohol soluble protein gene and application thereof |
US9497908B2 (en) | 2011-02-07 | 2016-11-22 | Hexima Limited | Modified plant defensins useful as anti-pathogenic agents |
US9848603B2 (en) | 2008-02-01 | 2017-12-26 | Hexima Limited | Methods for protecting plants with antifungal compositions |
US9889184B2 (en) | 2008-08-05 | 2018-02-13 | Hexima Limited | Anti-pathogen systems |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110240638B (en) * | 2019-06-10 | 2021-11-05 | 山东农业大学 | A kind of antibacterial peptide constructed by bioinformatics method and its application |
CN110204602B (en) * | 2019-06-10 | 2021-11-23 | 山东农业大学 | Antifungal antibacterial peptide and application thereof |
CN110684092B (en) * | 2019-06-10 | 2021-11-05 | 山东农业大学 | Antibacterial peptide and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135343A1 (en) * | 1983-08-19 | 1985-03-27 | Agricultural Genetics Company Limited | Plant protection method |
EP0348348A2 (en) * | 1988-06-20 | 1989-12-27 | Ciba-Geigy Ag | Process for controlling plant pests |
EP0352010A1 (en) * | 1988-07-12 | 1990-01-24 | Humber Growers Limited | Combating of undesired organisms |
EP0375091A1 (en) * | 1988-12-21 | 1990-06-27 | Institut Für Genbiologische Forschung Berlin Gmbh | Wound-inducible and potato tuber-specific transcriptional regulation |
WO1991018512A1 (en) * | 1990-05-25 | 1991-12-12 | Washington State University Research Foundation, Inc. | Method of inducing plant defense mechanisms |
-
1991
- 1991-09-02 GB GB9118730A patent/GB9118730D0/en active Pending
-
1992
- 1992-08-28 AU AU24847/92A patent/AU665020B2/en not_active Ceased
- 1992-08-28 JP JP5505025A patent/JPH06510535A/en active Pending
- 1992-08-28 NZ NZ244127A patent/NZ244127A/en unknown
- 1992-08-28 EP EP92918332A patent/EP0602098A1/en not_active Withdrawn
- 1992-08-28 WO PCT/GB1992/001574 patent/WO1993004586A1/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135343A1 (en) * | 1983-08-19 | 1985-03-27 | Agricultural Genetics Company Limited | Plant protection method |
EP0348348A2 (en) * | 1988-06-20 | 1989-12-27 | Ciba-Geigy Ag | Process for controlling plant pests |
EP0352010A1 (en) * | 1988-07-12 | 1990-01-24 | Humber Growers Limited | Combating of undesired organisms |
EP0375091A1 (en) * | 1988-12-21 | 1990-06-27 | Institut Für Genbiologische Forschung Berlin Gmbh | Wound-inducible and potato tuber-specific transcriptional regulation |
WO1991018512A1 (en) * | 1990-05-25 | 1991-12-12 | Washington State University Research Foundation, Inc. | Method of inducing plant defense mechanisms |
Non-Patent Citations (5)
Title |
---|
Bot. Bull. Academia Sinica, Vol. 33, No. 2, April 1992 R.H. Sammour et al.: "Antimicrobial activity of legume seed proteins ", * |
Journal of Biological Chemistry, Vol. 267, No. 22, August 1992 F.R.G. Terras et al.: "Analysis of Two Novel Classes of Plant Antifungal Proteins from Radish (Raphanus sativus L.) Seeds ", * |
MOLECULAR PLANT-MICROBE INTERACTIONS, Vol. 4, No. 4, 1991 Alison J. Vigers et al.: "A New Family of Plant Antifungal Proteins ", * |
Patent Abstracts of Japan, Vol 7, No 114, C166, abstract of JP 58- 32808, publ 1983-02-25 * |
PHYSIOLOGIA PLANTARUM, Vol. 80, 1990 Klaus Apel et al.: "Leaf thionins, a novel class of putative defence factors ", * |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5559034A (en) * | 1987-10-02 | 1996-09-24 | Ciba-Geigy Corporation | Synergistic antifungal protein and compositions containing same |
US5703044A (en) * | 1987-10-02 | 1997-12-30 | Novartis Finance Corporation | Synergistic antifungal protein and compositions containing same |
US5981844A (en) * | 1987-10-02 | 1999-11-09 | Novartis Finance Corporation | Synergistic antifungal protein and compositions containing same |
EP0712272A4 (en) * | 1993-07-16 | 1997-08-20 | Salk Inst For Biological Studi | TRANGENIC PLANTS CONTAINING MULTIPLE DISEASE RESISTANCE GENES |
WO1995018859A1 (en) * | 1994-01-10 | 1995-07-13 | Ciba-Geigy Ag | Synergistic antifungal protein and compositions containing same |
US6316407B1 (en) | 1996-12-13 | 2001-11-13 | Monsanto Company | Antifungal polypeptide from alfalfa and methods for controlling plant pathogenic fungi |
US6916970B2 (en) | 1996-12-13 | 2005-07-12 | Monsanto Technology, Llc | Transgenic plants comprising antifungal polypeptides from alfalfa and methods for controlling plant pathogenic fungi |
US6121436A (en) * | 1996-12-13 | 2000-09-19 | Monsanto Company | Antifungal polypeptide and methods for controlling plant pathogenic fungi |
US6599514B1 (en) | 1997-07-10 | 2003-07-29 | Syngenta Limited | Antifungal composition |
AU718210B2 (en) * | 1997-09-08 | 2000-04-13 | National Institute Of Agrobiological Sciences | Disease resistant plant including thionin gene |
US6187995B1 (en) | 1997-09-08 | 2001-02-13 | Director General Of National Institute Of Agrobiological Resources, Ministry Of Agriculture, Forestry And Fisheries | Method for producing disease resistant plant with thionin gene from Avena sativa |
NL1011688C2 (en) * | 1998-03-27 | 2001-09-13 | Academia Sinica | Amphipathic Protein-1. |
FR2778407A1 (en) * | 1998-05-11 | 1999-11-12 | Agronomique Inst Nat Rech | Use of polypeptide as insecticide, especially for controlling cereal grain pests |
WO1999058695A1 (en) * | 1998-05-11 | 1999-11-18 | Institut National De La Recherche Agronomique | USE OF A POLYPEPTIDE DERIVED FROM A PA1b LEGUME ALBUMEN AS INSECTICIDE |
WO2000071735A1 (en) * | 1999-05-21 | 2000-11-30 | Syngenta Limited | Composition of plant antimicrobial proteins |
US7544861B2 (en) * | 2001-02-08 | 2009-06-09 | Hexima Limited | Defensin-encoding nucleic acid molecules, uses therefor and transgenic plants comprising same |
US8252898B2 (en) | 2001-02-08 | 2012-08-28 | Hexima Limited | Defensin-encoding nucleic acid molecules derived from Nicotiana alata, uses therefor and transgenic plants comprising same |
US8722968B2 (en) | 2001-02-08 | 2014-05-13 | Hexima Limited | Defensin-encoding nucleic acid molecules derived from Nicotiana alata, uses therefor and transgenic plants comprising same |
US9848603B2 (en) | 2008-02-01 | 2017-12-26 | Hexima Limited | Methods for protecting plants with antifungal compositions |
US9889184B2 (en) | 2008-08-05 | 2018-02-13 | Hexima Limited | Anti-pathogen systems |
CN101544982B (en) * | 2008-12-09 | 2011-05-04 | 四川农业大学 | Novel nucleic acid sequence of gamma-alcohol soluble protein gene and application thereof |
US9497908B2 (en) | 2011-02-07 | 2016-11-22 | Hexima Limited | Modified plant defensins useful as anti-pathogenic agents |
US10174339B2 (en) | 2011-02-07 | 2019-01-08 | Hexima Limited | Modified plant defensins useful as anti-pathogenic agents |
Also Published As
Publication number | Publication date |
---|---|
AU2484792A (en) | 1993-04-05 |
AU665020B2 (en) | 1995-12-14 |
GB9118730D0 (en) | 1991-10-16 |
NZ244127A (en) | 1994-12-22 |
JPH06510535A (en) | 1994-11-24 |
EP0602098A1 (en) | 1994-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0603216B1 (en) | Biocidal proteins | |
US5824869A (en) | Biocidal proteins | |
US5942663A (en) | Biocidal proteins | |
AU665020B2 (en) | Biocidal proteins | |
US6521590B1 (en) | Biocidal proteins | |
US5773694A (en) | Antimicrobial proteins from Allium | |
US5861480A (en) | Antimicrobial proteins from aralia and impatiens | |
EP0672146B1 (en) | Biocidal chitin binding proteins | |
EP0593501B1 (en) | Biocidal proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MN MW NO PL RO RU SD US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992918332 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1994 199325 Date of ref document: 19940302 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1992918332 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992918332 Country of ref document: EP |